PeptideDB

Lamotrigine-13C2,15N2,d3

CAS: F: C713C2H5D3Cl2N315N2 W: 264.09

Lamotrigine-13C2,15N2,d3 is 15N and deuterated labeled Lamotrigine (HY-B0495). Lamotrigine (BW430C) is a potent and oral
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity Lamotrigine-13C2,15N2,d3 is 15N and deuterated labeled Lamotrigine (HY-B0495). Lamotrigine (BW430C) is a potent and orally active anticonvulsant or antiepileptic agent. Lamotrigine selectively blocks voltage-gated Na+ channels, stabilizing presynaptic neuronal membranes and inhibiting glutamate release. Lamotrigine can be used for the research of epilepsy,?focal seizure, et al[1][2].
Invitro 氢、碳和其他元素的稳定重同位素已被纳入药物分子中,主要作为药物开发过程中定量的示踪剂。氘化引起了人们的关注,因为它可能影响药物的药代动力学和代谢谱[1]。Lamotrigine 抑制藜芦碱引起的谷氨酸和天冬氨酸释放,两种氨基酸的 ED50 值为 21 μM,但 Lamotrigine 抑制 GABA 释放的效力较低 (ED50= 44 μM。在浓度高达 300 μM 时,LTG 对钾诱发的氨基酸没有影响[2]。 Lamotrigine 抑制藜芦碱诱发的氨基酸的效力大约低五倍[3H]乙酰胆碱释放 (ED50=100 μM) 低于谷氨酸或天冬氨酸释放[2]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. 0 --> Lamotrigine-13C2,15N2,d3 相关抗体:
In Vivo Lamotrigine(腹腔注射,在戊四氮前 30 分钟;10 mg/kg、15 mg/kg 或 20 mg/kg)会降低较高剂量下的癫痫发作强度,与对照组相比,在所有研究剂量中 Lamotrigine 都会增加首次戊四氮诱发癫痫发作的潜伏期[3]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Formula C713C2H5D3Cl2N315N2
Molar Mass 264.09
Transport Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Reference [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [2]. M J Leach, et al. Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action. Epilepsia. Sep-Oct 1986;27(5):490-7. [3]. Damianka P Getova, et al. A study of the effects of lamotrigine on mice using two convulsive tests. Folia Med (Plovdiv). Apr-Jun 2011;53(2):57-62.